Contributing to a Sustainable Society Through the Resolution of Healthcare Issues and Environmental Action, Governance, and Diversity
First written in FY2017. 4 of 9 entries say "Advanced", first in FY2021. Latest entry: 2026-10-01.
The whole theme swung hardest in 2017: 1 of 8 companies on the "Worse" side.
19 other companies' latest entry also says "Reframed".
- 2026-10-01ReframedGovernance
「In 2026, coinciding with the launch of the new medium-term management plan for fiscal 2026 through fiscal 2028, we reorganized the social issues faced by each stakeholder, including healthcare issues, and reformulated our materiality to strengthen its alignment with our strategy through a more quantitative approach.」
Materiality was reorganized from 5 fields and 14 items to 6 themes and 17 items, strengthening its alignment with the new medium-term management plan. - FY2026AdvancedAnnual report
「We endorsed the recommendations of the TNFD and registered as the first TNFD Adopter in the industry. We also obtained SBTi certification and were selected for the A List, its highest rating, in CDP’s 2025 assessment, which is the world’s only independent environmental disclosure program.」
It disclosed specific external recognition and achievements in environmental initiatives, including registration as a TNFD Adopter, obtaining SBTi certification and selection for the CDP A List. - FY2024AdvancedAnnual report
「To achieve carbon neutrality by 2040, we will promote the elimination of plastics by switching packaging materials and consumables to environmentally responsible materials. We will also create green innovation based on the 4Rs across the entire value chain and transform it into a circular value chain that avoids wasting resources through open innovation with customers, alliance partners, other companies and suppliers.」
It made the environmental initiatives concrete by switching packaging materials and consumables to environmentally responsible materials toward carbon neutrality by 2040, eliminating plastics, and creating a circular value chain based on the 4Rs. - FY2024-Q2AdvancedAnnual report
「The renewal of the GBP agreement includes the renewal of a non-exclusive collaboration agreement concerning projects in which a customer seeks biochemical and immunoassay products and hematology products simultaneously from a single company, as well as the addition of a collaboration agreement providing for the launch of discussions on collaboration themes aimed at resolving environmental issues.」
Regarding contributions to a sustainable society, it added to the collaboration agreement with Roche provisions to begin considering collaboration themes aimed at resolving environmental issues. - FY2023RaisedAnnual report
「We have formulated “シスメックス・エコビジョン2033” as a long-term guide for environmental management and will continue to promote reductions in CO2 emissions and water consumption across the product life cycle, environmentally responsible green procurement and other initiatives.」
It updated its long-term environmental policy from the previous “シスメックス・エコビジョン2025” to “シスメックス・エコビジョン2033.” It set time-bound and quantitative targets, including a declaration to achieve carbon neutrality by 2040, a 55% reduction in Scope 1 and 2 emissions and a 35% reduction in Scope 3 emissions by fiscal 2033, and a 90% renewable-energy ratio. - FY2022Made environmental and sustainability initiatives concreteAnnual report
「As global environmental sustainability has become an urgent issue, we recognize that reducing the environmental impact of our business activities is an important issue for a global company. We have formulated “シスメックス・エコビジョン2025” as a long-term guide for environmental management and will continue to promote reductions in CO2 emissions and water consumption across the product life cycle, environmentally responsible green procurement and other initiatives.」
It made the previous initiatives addressing healthcare challenges, the environment and governance concrete through “シスメックス・エコビジョン2025,” reductions in CO2 emissions and water consumption, and green procurement. - FY2021AdvancedAnnual report
「Based on our materialities and sustainability targets, including addressing healthcare challenges, improving quality, strengthening environmental initiatives and reinforcing governance, we will implement initiatives across the Group to earn the trust of diverse stakeholders and enhance corporate value.」
It made the previous initiatives addressing healthcare challenges, the environment, governance and diversity concrete through Group-wide measures based on materialities and sustainability targets. - FY2018RestatedAnnual report
「In addition to addressing healthcare challenges through our products and services, we will provide unique new value from シスメックス to diverse stakeholders and contribute to social development through environmental stewardship, stronger corporate governance and the promotion of diversity.」
It reiterates the integrated sustainability initiatives addressing healthcare challenges, the environment, governance and diversity. - FY2017First statedAnnual report
「To help realize a sustainable society, we will address medical challenges through the provision of products and services, while providing new value unique to Sysmex to diverse stakeholders through environmental stewardship, stronger corporate governance, and the promotion of diversity.」
It presents for the first time, as a standalone initiative, a sustainability program addressing healthcare challenges, the environment, corporate governance and diversity in an integrated manner.